| I. | Technical Methods |
| D-timer testing | |
| INR | |
| Molecular diagnosis in assessment of hypercoagulability | |
| II. | Blood Vessels |
| III. | Platelets |
| Heparin-induced thrombocytopenia | |
| Common platelet function disorders | |
| IV. | Coagulation |
| General concepts and
role of the following: Recombinant factor VIIa in treatment of bleeding disorders and massive hemorrhage Plasminogen activators and inhibitors in thrombosis Thrombin-activatable fibrinolysis inhibitor in thrombosis Natural inhibitors of coagulation | |
| Anticoagulant therapy Indications for LMW heparin and how to monitor Direct thrombin inhibitors Platelet inhibitors & other antiplatelet therapy | |
| Aspirin resistance | |
| Warfarin resistance | |
| ADAMS13 and TTP | |
| D-dimers and PE screening | |
| Hypercoagulable states-diagnosis | |
| Lupus anticoagulants-lab tests, clinical implications | |
| References |